Stockscreener 앱 받기
0.405
3.87%
-0.0163
시간 외 거래:
.42
0.015
+3.70%
전일 마감가:
$0.4213
열려 있는:
$0.4159
하루 거래량:
555.31K
Relative Volume:
0.11
시가총액:
$3.01M
수익:
$79,300
순이익/손실:
$-6.92M
주가수익비율:
-0.0213
EPS:
-18.9818
순현금흐름:
$-5.34M
1주 성능:
+17.12%
1개월 성능:
-35.67%
6개월 성능:
-52.91%
1년 성능:
-85.38%
1일 변동 폭
$0.405
$0.43
1주일 범위
$0.3251
$0.4384
52주 변동 폭
$0.31
$2.73
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
VRAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.405 | 3.13M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 개시 | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd 주식(VRAX)의 최신 뉴스
Virax Biolabs Releases Interim Financial Results for September 2025 - The Globe and Mail
Is Virax Biolabs Group Limited stock positioned for long term growthJuly 2025 Update & Real-Time Market Trend Scan - Улправда
Can Virax Biolabs Group Limited stock beat market expectations this quarterWeekly Market Outlook & Real-Time Sentiment Analysis - Улправда
Virax Biolabs (NASDAQ: VRAX) details 25.9M-share resale from $5M raise - Stock Titan
Virax Biolabs secures $5 million in private placement to advance immunology research - MSN
Virax Biolabs Group (NASDAQ:VRAX) Shares Down 11.3% – Here’s Why - Defense World
A new trading data show Virax Biolabs Group Ltd (VRAX) is showing positive returns. - Setenews
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Penny Stocks To Keep An Eye OnDecember 3rd - MarketBeat
Why Virax Biolabs Group Limited stock is seen as undervalued2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Virax Biolabs Secures $5 Million in Private Placement to Advance Immunology Research - The Globe and Mail
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Virax Biolabs (Nasdaq: VRAX) closes $5 million raise, cash runway into 2028 - Stock Titan
US Market Preview | VRAX Surges 108.0%; ADP Jobs Data Misses Expectations, Futures Rise; NVDA's OpenAI Investment Pending - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Healthy Upside Potential: Transocean Ltd (RIG) - Setenews
Ready to Jump After Recent Trade: Virax Biolabs Group Ltd (VRAX) - setenews.com
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally - Benzinga
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.86% - Investing.com UK
United States shares higher at close of trade; Dow Jones Industrial Average up 0.86% By Investing.com - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.86% - Investing.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Scienjoy (NASDAQ: SJ): Deep-Value, Cash-Rich Tech with Mixed-Reality Upside More Inside - openPR.com
Virax Biolabs Group Limited (VRAX) Stock: Surges as 2026 Strategy and Clinical Milestones Ignite Investor Interest - parameter.io
Virax Biolabs : Announces $5 Million Private Placement - marketscreener.com
Virax Biolabs (Nasdaq: VRAX) announces $5 million private placement for working capital - Stock Titan
Crude Oil Gains 1%; Macy's Reports Strong Q3 Results - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
BC-Most Active Stocks - Yahoo Finance
Ming Shing Group (NASDAQ: MSW) adds Tianhang Zhao to Board, audit chair named - Stock Titan
US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Benzinga
Virax Biolabs stock rockets after clinical progress in post-infection diagnostics By Investing.com - Investing.com South Africa
Virax Biolabs stock rockets after clinical progress in post-infection diagnostics - Investing.com India
Credo Technology Group (NASDAQ: CRDO) to present at Barclays 23rd Global Technology Conference on Dec. 10 - Stock Titan
The LGL Group (NYSE American: LGL) moves warrant deadline from Dec. 9 to Dec. 16, 2025 - Stock Titan
Nu Holdings (NYSE: NU) to add Brazil banking license without changing Nubank brand - Stock Titan
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - PR Newswire
Virax Biolabs Group (VRAX) Stock Analysis Report | Financials & Insights - Benzinga
Will Virax Biolabs Group Limited stock maintain dividend yield - Newser
Mitsubishi UFJ (NYSE: MUFG) details ¥250B share buyback and 200M-share cancellation - Stock Titan
Is Virax Biolabs Group Limited stock a defensive play in 2025Global Markets & Daily Profit Focused Stock Screening - moha.gov.vn
A new trading data show Foremost Clean Energy Ltd (FMST) is showing positive returns. - Setenews
Get in on Titan Mining Corp’s (TII) buy-in window today! - Setenews
A Look at Virax Biolabs Group Ltd (VRAX) Shares in the Recent Past Indicates Growth - setenews.com
Republic Power (NASDAQ: RPGL) Notified of Noncompliance for 2025 Form 20-F Filing - Stock Titan
MUFG (NYSE: MUFG) rings NYSE Closing Bell to honor 20th merger anniversary - Stock Titan
EPWK Holdings (Nasdaq: EPWK) receives Nasdaq delisting notice under Rule 5250(c)(1) - Stock Titan
How Virax Biolabs Group Limited stock reacts to bond yieldsVolume Spike & Daily Growth Stock Tips - newser.com
Why Virax Biolabs Group Limited stock is favored by pension fundsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Virax Biolabs Group (NASDAQ:VRAX) Trading Down 0% – Time to Sell? - Defense World
Virax Biolabs Group Ltd (VRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):